SC-26196

CAS : 218136-59-5

Ref. 3D-TIA13659

Informations sur le produit

• Nom: SC-26196
• Marque: Biosynth
• Description: SC-26196 is a potential new anti-cancer drug that inhibits the activation of fatty acid receptors. SC-26196 blocks receptor activity, which reduces the growth of cancer cells in cell culture. This drug also has inhibitory properties on tumor growth in xenograft mice, and may be useful for the treatment of cardiac dysfunction or other diseases related to fatty acid metabolism. SC-26196 is a complex molecule with high potential for drug interactions. It is a polyunsaturated molecule that can be activated by radiation and has been shown to have cardioprotective effects in rats with myocardial infarction.

Propriétés chimiques

• Masse moléculaire: 423.55 g/mol
• Formule: C₂₇H₂₉N₅
• Degré de pureté: Min. 95%